Lenvatol 4 mg
Lenvatol 4 mg capsules are used to treat thyroid cancer that has metastasized to other parts of the body or has recurred locally.
Lenvatinib 4 mg capsules are also used to treat liver cancer in patients who cannot undergo surgery.
Lenvatol 4 mg capsules prevent cancer metastasis by blocking the supply of oxygen to cancer cells and stopping their growth. May be taken with or without food on doctor’s advice.
Uses of Lenvatol 4 mg Capsules
- Thyroid cancer
- Unresectable hepatocellular carcinoma (HCC)
- Advanced renal cell carcinoma (RCC)
Benefits of Lenvatol 4 mg
Lenvatol 4 mg Capsules is an anticancer drug that acts as a kinase inhibitor for the vascular endothelial growth factor receptor VEGFR and is primarily used to treat certain types of thyroid cancer.
How do Lenvatol 4 mg capsules work?
Lenvatol 4mg capsules work by blocking enzymes called tyrosine kinases that supply oxygen and nutrients to cancer cells.
How to use Lenvatol 4 mg?
Take this medicine for the dose and duration recommended by your doctor. Lenvatol 4 mg capsules can be taken with or without food, but it is best to take them at regular times.
- Loss of appetite
- Erythema (skin redness)
- Hoarseness of voice
- joint pain
- sore mouth
- Muscle pain
- Peripheral edema
- Peeling of the skin
- stomach ache
- Lenvatol 4 mg capsules are used to treat thyroid cancer.
- Take it with or without food, preferably at the same time each day.
- Diarrhea may occur as a side effect. Drink plenty of fluids and let your doctor know if it doesn’t stop or if you have blood in your stool.
- Use reliable birth control to avoid pregnancy while taking this medicine and for 1 month after you stop taking it.
- Monitor your blood pressure regularly while taking this medicine. See your doctor if you notice symptoms of high blood pressure, such as severe headache, confusion, blurred vision, nausea or vomiting.
- This can lead to serious bleeding problems. Call your doctor if you have a headache, stomach pain, or blood in your urine or stool.
- Do not take this medicine if you are pregnant, planning to become pregnant, or breastfeeding.
Lenvatinib should be used with caution in the following conditions:
- Hypertension: Check your blood pressure before treatment and monitor it during treatment. Discontinue for grade 3 hypertension despite optimal antihypertensive therapy. Discontinue for grade 4 hypertension.
- Cardiac dysfunction: Be aware of clinical symptoms or signs of cardiac dysfunction. Discontinue or discontinue for Grade 3 cardiac dysfunction. Discontinue for Grade 4 cardiac dysfunction.
- Arterial thromboembolism: Discontinue after the occurrence of arterial thromboembolism.
- Hepatotoxicity: Monitor liver function before and regularly during treatment. Discontinue or discontinue for grade 3 or 4 hepatotoxicity.
- Renal Failure or Injury: Discontinue or discontinue for Grade 3 or 4 renal failure or injury.
- Proteinuria: Monitor proteinuria before and regularly during treatment. Maintain proteinuria >2 grams per 24 hours. Discontinue for nephrotic syndrome.
- Diarrhea: May be severe and recurrent. For severe diarrhea, start treatment promptly. Pause or stop depending on severity.
- Gastrointestinal Fistula Formation and Perforation: Discontinue treatment in patients who develop a Grade 3 or 4 fistula or any grade of gastrointestinal perforation.
- Hypocalcaemia: Monitor blood calcium levels at least monthly and replenish calcium as needed. Pause or stop depending on severity.